Publications

Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis

 76
Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis

Tags:

Previous Article

Post Translation Modification

Next Article

Treatment of IL-18-binding protein biologics to treat liver disease

Related Posts

Host-pathogen interactions in the Plasmodium-infected mouse liver at spatial and single-cell resolution

Host-pathogen interactions in the Plasmodium-infected m...

 45

Hydrogen sulfide coordinates glucose metabolism switch through destabilizing tetrameric pyruvate kinase M2

Hydrogen sulfide coordinates glucose metabolism switch ...

 41

Transcriptional signatures of hippocampal tau pathology in primary age-related tauopathy and Alzheimer’s disease

Transcriptional signatures of hippocampal tau pathology...

 30